<p>College Clinical Advisers Denise Voon MCOptom, Dr Paramdeep Bilkhu MCOptom, and Daniel Hardiman-McCartney FCOptom MBE discuss the recent news from the Medicines and Healthcare products Regulatory Agency (MHRA) approving the first low-dose atropine treatment for myopia in the UK. </p><p>They talk about what the news means for optometrists and answer questions from College members. </p><p><strong>Further information</strong></p><ul><li><a href="https://www.college-optometrists.org/category-landing-pages/clinical-topics/myopia">Myopia management</a></li><li><a href="https://www.college-optometrists.org/clinical-guidance/guidance/knowledge,-skills-and-performance/assessing-and-managing-children-with-myopia">Guidance for assessing and managing children with myopia</a></li><li><a href="https://www.college-optometrists.org/news/2025/november/mhra-licensed-low-dose-atropine-myopia">MHRA approves first licensed low-dose atropine treatment for childhood myopia in the UK</a></li><p><a href="https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Prescribing%20Competency%20Framework/RPS%20-%20Scope%20of%20Practice-English-220601.pdf?ver=fNYC4O_ThDfE3AsC01HvFw%3D%3D">Expanding Prescribing Scope of Practice - Royal Pharmaceutical Society</a></p></ul>